Canpolat, Temel Pediatrik EpilepsiYiğithan Güzin, Serdar Pekuz, Aycan Ünalp et al.|Unknown|2024Cited by 0
607PEvaluation of clinical features of patients diagnosed with spinal muscular atrophy type 1 receiving nusinersen treatment before and after newborn screening program: a multicenter experience in TurkiyeMustafa Kömür, E. Sarıgecilli, Sema Saltık et al.|Neuromuscular Disorders|2025Cited by 0
Effects of newborn screening and nusinersen on survival and functional outcomes in spinal muscular atrophy with two SMN2 copies: A nationwide multicentre real-world study from TurkeyMustafa Kömür, Hüseyin Tan, Ezgi Çağlar et al.|European Journal of Paediatric Neurology|2026Cited by 0